Physician profile
Edwin Yu
NPI 1467597575
$1,701.37
in general payments reported to CMS, 2019-2025
16 companies · $17.98 in 2025
The $17.98 reported for 2025 was less than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $875 · 2020: $518 · 2021: $96.06 · 2022: $47.15 · 2023: $148 · 2025: $17.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $165.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $382.47 | 2019-2020 | |
| Boston Scientific Corporation | $194.68 | 2022-2023 | Ingevity Mri, Accolade Sr, Zoom Wireless Transmitter |
| Gilead Sciences, INC. | $162.39 | 2019-2021 | |
| Melinta Therapeutics, LLC | $153.21 | 2019-2020 | |
| Viiv Healthcare Company | $132.40 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $123.46 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $118.46 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $88.76 | 2019-2020 | |
| Insmed, INC. | $63.79 | 2019-2021 | |
| Janssen Biotech, INC. | $60.17 | 2019-2020 | |
| Astellas Pharma US INC | $54.86 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $48.25 | 2019-2020 | |
| Abbvie INC. | $46.36 | 2021-2025 | |
| Theratechnologies INC. | $32.77 | 2019 | |
| La Jolla Pharmaceutical Company | $27.86 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $11.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.